Home
>
US Stocks
>
Black Diamond Therapeutics Inc
Black Diamond Therapeutics Inc
BDTX

Black Diamond Therapeutics Inc (BDTX)

$8.1214.35%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
7.98
Today Low/High
7.98 / 8.31
52 Week Low/High
$8.75 / $37.76
Market Cap
$337.87M

Company Details

Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery of small molecule, tumor-agnostic therapies. Black Diamond targets undrugged mutations in patients with genetically defined cancers. Black Diamond is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry. The Company's proprietary technology platform, Mutation-Allostery-Pharmacology, or MAP, platform, is designed to allow Black Diamond to analyze population-level genetic sequencing data to identify oncogenic mutations that promote cancer across tumor types, group these mutations into families, and develop a single small molecule therapy in a tumor-agnostic manner that targets a specific family of mutations. Black Diamond was founded by David M. Epstein, Ph.D., and Elizabeth Buck, Ph.D., and, beginning in 2017, together with Versant Ventures, began building the MAP platform and chemistry discovery engine.
Organisation
Black Diamond Therapeutics Inc
Employees
73
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Black Diamond Therapeutics Inc (BDTX) share price today?

Can Indians buy Black Diamond Therapeutics Inc (BDTX) shares?

How can I buy Black Diamond Therapeutics Inc (BDTX) shares from India?

Can Fractional shares of Black Diamond Therapeutics Inc (BDTX) be purchased?

What are the documents required to start investing in Black Diamond Therapeutics Inc (BDTX) stocks?

We are a SEBI registered investement advisor